ELIGIBILITY AND PROTEOMIC CLUSTER PROFILES OF REAL-WORLD PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION IN LANDMARK SGLT2-INHIBITOR TRIALSJerremy Weerts,Sanne Mourmans, Eva Borras, Arantxa Barandiaran,Maurits Sikking,Sandra van Wijk,Hans-Peter Brunner-La Rocca,Anouk Achten,Ernst R. Rietzschel,Christian Knackstedt,Payman Zamani, Aryeh Fischer,Lei Zhao, Juan Maya,Julio A. Chirinos,Oriol Iborra Egea,Antoni Bayes-Genis,Vanessa Van EmpelJournal of the American College of Cardiology(2024)引用 0|浏览30暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要